Menu
Recent updates as of 05/17/2021

2021 SIPS Conference Parallel Workshop Sessions

Parallel Workshop Session 1
(Date: May 26th, 2021 / Time: 10:10 AM – 11:40 AM)

Session S1.1 – Using the balanced placebo design to investigate the role of expectancy in drug-related responses: Applications in nicotine and opioid models.

Chair: Lauren Atlas, PhD

 

  • How expectation influences brain and behavioral responses to opioid analgesia

 

Presenter
Lauren Atlas, PhD
Chief, Section on Affective Neuroscience and Pain, NIH (NCCIH, NIMH, NIDA)

  • The role of expectancy in recovery from a smoking lapse during a simulated quit attempt

 

Presenter
Laura Juliano, PhD
Professor, Department of Psychology, American University, Washington D.C. 20016

  • Dose-dependent effect of beliefs about nicotine on the human brain

 

Presenter
Xiaosi Gu, PhD
Director, Computational Psychiatry Unit, Associate Professor, Psychiatry & Neuroscience, Friedman Brain Institute & Addiction Institute, Icahn School of Medicine at Mount Sinai


Session S1.2 – Predictability of clinical placebo response

Chair: Vania Apkarian, PhD – Director Center for Translational Pain Research, Director Center of Excellence for Chronic Pain and Drug Abuse Research, Professor of Physiology, Anesthesia, PM&R, Northwestern University, Feinberg School of Medicine

 

  • Is it possible to predict who will be a placebo responder? Theoretical and empirical considerations

 

Presenter
Tor Wager, PhD
Diana L. Taylor Distinguished Professor, Presidential Cluster in Neuroscience and Department of Psychological and Brain Sciences, Dartmouth College

  • Predictability of clinical placebo response using brain and psychological biomarkers

 

Presenter
Etienne Vachon-Presseau, PhD
Assistant Professor, School of Dentistry, McGill University

  • Predictability of clinical placebo response based on language use

 

Presenter
Paulo Branco, PhD
Postdoctoral Research Fellow at Northwestern University

  • Genetic predictors of placebo response

 

Presenter
Kathryn Hall, PhD, MPH
Director of Basic and Translational Research, Osher Center for Integrative Medicine, Associate Molecular Biologist, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School


Session S1.3 – Expectations: What do we know and where do we need to go?

Chair: Lene Vase, DMSc, PhD, MSc

 

  • Do expectations contribute to placebo analgesia effects?

 

Presenter
Lene Vase, DMSc, PhD, MSc
Professor, Psykologisk Institut, Aarhus Universitet, Denmark

  • Hoping for the best, but expecting the worse

 

Presenter
Irving Kirsch, PhD
Associate Director, Program in Placebo Studies, Harvard Medical School; Professor Emeritus of Psychology: University of Connecticut (USA) and University of Hull (UK)

  • Rethinking expectations

 

Presenter
Christian Büchel, MD
Professor of Cognitive Neuroscience, Director Department for Systems Neuroscience, University Medical Center, Hamburg-Eppendorf, Germany

  • The role of expectancy, placebo effects and analgesic treatment outcome

 

Presenter
Ulrike Bingel, MD, PhD
Professor of Neurology, Medical Faculty, University of Duisburg-Essen, Germany


Session S1.4 – Placebo and Nocebo Effects in Affective Disorders.

Chair: Winfried Rief, PhD

 

  • Placebo effects in the treatment of depression and the implications for pharmacological and psychotherapeutic interventions

 

Presenter
John Kelley

  • Nocebo effects and expectation mediated adverse events in the treatment of depression

 

Presenter
Yvonne Nestoriuc

  • The role of expectation acquisition, persistence, and change for the understanding of depression leads to the development of a new model on affective disorders, and helps to improve and optimize treatment programs.

 

Presenter
Winfried Rief, PhD
Professor of Clinical Psychology and Psychotherapy, University of Marburg, Germany


Session S1.5 – Dynamic regulation of genes in placebo responsiveness in pain and alcohol use disorders.

Chair: Chamindi Seneviratne

 

  • Gene expression and placebo effects in chronic pain patients

 

Presenter
Susan G. Dorse

  • Is there still a value to use Single Nucleotide Polymorphisms to predict responses to placebo?

 

Presenter
Luana Colloca

  • Harnessing genomic regulation by placebo effects underlying alcohol consumption: A transcriptome-wide gene expression analysis

 

Presenter
Chamindi Seneviratne


Parallel Workshop Session 2
(Date: May 27th, 2021 / Time: 9:00 AM – 10:30 AM)

Session S2.1 – Using the Person-Based Approach to Implement Placebo Research into Primary Care.

Chair: Felicity Bishop

 

  • Planning “Empathico” using qualitative research, evidence, and theory

 

Presenter
Jane Vennik

  • Optimising “Empathico” using iterative qualitative research

 

Presenter
Kirsten Smith

  • Getting ready to test “Empathico”:  A feasibility trial in general practice

 

Presenter
Felicity Bishop


Session S2.2 – Immersive virtual reality to induce a positive therapeutic experience in musculoskeletal pain patients.

Chair: Marco Testa

 

  • The behavioural and physiological mechanisms to modulate pain by immersive virtual reality

 

Presenter
Luana Colloca

  • Virtual reality for chronic pain

 

Presenter
Beth Darnall

  • Implementing immersive virtual reality in musculoskeletal physiotherapy to improve motor performance and pain. Preliminary results

 

Presenter
Marco Testa


Session S2.3 – Putting placebos into practice: From mechanisms to making patients better.

Chair: Jeremy Howick

 

  • Evidence for ethical benefits of placebo effects has reached a turning point

 

Presenter
Jeremy Howick

  • Harnessing placebo effects in clinical practice: real experiences in treating pain

 

Presenter
Damien Finniss

  • Learning mechanisms of placebo effects in pain: Translating science into clinical practice

 

Presenter
Babel Przemyslaw


Session S2.4 – Placebo meets proteomics.

Chair: Karin Meissner

 

  • Proteomic classification of the placebo effect in nausea – an experimental study

 

Presenter
Karin Meissner

  • Functional classification of placebo-associated protein changes and prediction of placebo responders in nausea

 

Presenter
Dominik Lutter

  • Mass spectrometry analysis of plasma samples from a placebo study in nausea

 

Presenter
Christine von Toerne


Session S2.5 – Nocebo in headaches.

Chair: Dimos D. Mitsikostas

 

  • Hypoxia and headache

 

Presenter
Fabrizio Benedetti

  • Q-No: A Screening tool to detect potential nocebo behaviours

 

Presenter
Christina Deligianni

  • Nocebo clinical trials for primary headaches and other neurological conditions

 

Presenter
Dimos D. Mitsikostas


Parallel Workshop Session 3
(Date: May 27th, 2021 / Time: 2:30 PM – 4:00 PM)

Session S3.1 – Role of Cues and Expectancies in Addiction: Recent Translational Efforts.

Chair: Lorenzo Leggio

 

  • Alcohol exposure alters cue-evoked neural responses that encode expected value

 

Presenter
Jocelyn Richard

  • How Adolescents’ in-the-Moment Alcohol Expectancies Shape Drinking Experiences in Daily Life

 

Presenter
Hayley Treloar Padovano

  • Cue Reactivity and Other Laboratory Paradigms Toward Medication Development in Addiction

 

Presenter
Lorenzo Leggio


Session S3.2 – Phenotypes supporting the association of sleep disturbance and endogenous pain modulation.

Chair: Luana Colloca

 

  • Good and poor sleepers: in search of critical determinants of placebo analgesic effects

 

Presenter
Luana Colloca

  • Sleep and descending pain modulation: Insights from experimental sleep disruption studies

 

Presenter
Patrick H. Finan

  • Does placebo analgesia conditioning is modulated by sleep in otherwise healthy subject? A mapping review.

 

Presenter
Gilles J Lavigne


Session S3.3 – Possible Placebo Mechanisms: Conditioned response, meaning making, and relationship.

Chair: Bruce E. Wampold

 

  • Healing in a Social Context: Evidence and Mechanisms

 

Presenter
Bruce E. Wampold

  • Empirical predictions consistent with the Conditioned Response Model of the Placebo

 

Presenter
Ian Wickramasekera

  • The Meaning Response

 

Presenter
Daniel Moerman


Session S3.4 – New Translational Opportunities for Placebo Research.

Chair: Marta Pecina

 

  • Neural Antidepressant Expectancies Moderate Antidepressant Treatment Response in Major Depression.

 

Presenter
Marta Pecina

  • Leveraging Placebo Effects in 21st Century Healthcare: New Frontiers for placebo research.

 

Presenter
Alia Crum

  • Leveraging placebo analgesia for clinical pain management.

 

Presenter
Ben Alter


Session S3.5 – Expectation/Placebo Effects in Behavioral Interventions for Cognitive Enhancement: Lessons from Outside Domains and Current Research.

Chair: C. Shawn Green
Moderator: Aaron Seitz

 

  • Placebo effects in the context of pain

 

Presenter
Tor Wager

  • Expectation effects in the context of cognitive training – early research

 

Presenter
Susanne Jaeggi

Co-Presenter
C. Shawn Green

  • Explicitly given and associative-learning based placebo effects in the context of a large-scale cognitive training study

 

Presenter
Jocelyn Parong


Parallel Workshop Session 4
(Date: May 28th, 2021 / Time: 9:00 AM – 10:30 AM)

Session S4.1 – Towards a better understanding of the placebo-effects of communication: from rationales and research to implications and training.

Chair: Liesbeth Van Vliet

 

  • Disentangling how communication can heal: studying the placebo-effects of communication from a communication perspective

 

Presenter
Liesbeth Van Vliet

  • Why is Research on Healthcare Communication so Difficult? Challenges and Opportunities

 

Presenter
John Kelly

  • Overcoming barriers to empathy training for healthcare students and practitioners

 

Presenter
Jeremy Howick

  • Training healthcare providers to use placebo effects in clinical practice

 

Presenter
Kari Leibowitz


Session S4.2 – Molecular Mechanisms of Placebo Response: From Genes to Pathways.

Chair: Kathryn Hall, PhD, MPH

 

  • Opoiod modulation of antidepressant placebo effects

 

Presenter
Marta Pecina

  • Pharmacogenomics of placebo response and remission in major depressive disorder

 

Presenter
Arun Tiwari

  • Genetic influences on placebo analgesia in clinical trials of irritable bowel syndrome

 

Presenter
Jan Vollert

  • What can genomics tell us about placebo response?

 

Presenter
Kathryn Hall, PhD, MPH
Director of Basic and Translational Research, Osher Center for Integrative Medicine, Associate Molecular Biologist, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School


Session S4.3 – The therapeutic encounter as placebo – parsing the psychological, sociocultural, and brain mechanisms of the patient-clinician interaction in pain treatment.

Chair: Dan-Mikael Ellingsen

 

  • The role of social learning in the acquisition of fear, avoidance behavior, and placebo responding

 

Presenter
Kai Karos

  • Brain-to-brain concordance and nonverbal behavioral mirroring as a mechanism of socially mediated placebo analgesia in the therapeutic encounter

 

Presenter
Dan-Mikael Ellingsen

  • The doctor-patient relationship and pain: Sociocultural and neural mechanisms

 

Presenter
Elizabeth Reynolds Losin


Session S4.4 – Placebo effects in pain management - practical implications.

Chair: Regine Klinger

 

  • How placebo effects can enrich clinical pain treatment and save opioids in acute pain management

 

Presenter
Regine Klinger

  • Effects of patients’ expectation in dermatology: Implications for dermatological practice and research

 

Presenter
Wiebke Sondermann

Co-Presenter
Manfred Schedlowski

  • Strategies for mitigating the negative effects of adverse event information: Evidence, ethical implication and clinical practice

 

Presenter
Lene Vase


Session S4.5 – Management of contextual factors to enhance placebo and avoid nocebo effects in clinical practice.

Chair: Marco Testa

 

  • Improvement of musculoskeletal pain patient's subjective outcomes by a positive management of contextual factors. A clinical guide

 

Presenter
Giacomo Rossettini

  • Mindsets matter: leveraging contextual factors to shape mindsets and enhance treatment outcome

 

Presenter
Diletta Barbiani

  • Therapeutic relationship and safety: being present and receptive in the clinical interaction

 

Presenter
Maxi Miciak


Session S4.6 – The placebo effect in the motor domain: from pathology to sport.

Chair: Mirta Fiorio

 

  • Placebo-induced motor improvements: from performance in motor disorders to performance at very high altitudes

 

Presenter
Fabrizio Benedetti

  • Beyond ergogenic aids: placebo effects on movement in sport performance

 

Presenter
Chris Beedie

  • Mind Over Matter: Placebo for Functional (Psychogenic) Movement Disorders

 

Presenter
Karen Rommelfanger